James E. Wagner Cultivation Corporation has entered into a brokerage agreement with Kindred Partners Inc., under which Kindred will serve as the exclusive broker for JWC’s adult use cannabis products in Canada. Kindred is a specialty brokerage and services company for cannabis products.
Kindred is a wholly owned subsidiary of Breakthru Beverage Group, LLC and has deep roots and experience in effectively managing distribution agreements in highly regulated industries. Kindred operates separately from its sister company, alcohol beverage brokerage Breakthru Beverage Canada, while leveraging related knowledge and expertise in working with Canadian Provincial control boards, licensed distributors and retailers. The collaboration will allow for Kindred to use its national presence to market the JWC brand throughout Canada, while offering industry intelligence and insights to better serve and supply the adult-use market.
“At JWC, our passion is our purpose. Our company values are reflective of a strong family culture,” said Nathan Woodworth, CEO of James E. Wagner Cultivation Ltd. “I’m looking forward to collaborating with Kindred. It was important for us to find a company that shares similar values, including a sense of authenticity, a responsible culture and a commitment to customers. I’m excited about the prospect of realizing our goal to expand our business across Canada.”
The Agreement is an important step for JWC in its preparations for entering the recreational cannabis markets in Canada in the coming weeks. Kindred provides a workforce with extensive experience of operating in a competitive consumer packaged goods environment.
“We’re excited to serve as the exclusive brokerage partner for James E. Wagner Cultivation Ltd. and their innovative aeroponic products across the Canadian market,” said David Prodanovic, VP, General Manager of Kindred Partners. “As the market continues to evolve, we intend to leverage our well-established business model to meet JWC’s brand goals.”
The Agreement also covers JWC’s derivative line of cannabis extract products currently under development and expected to come to market in the first calendar quarter of 2020. JWC will continue to market and sell cannabis products to its medical patients as well as directly to other licensed producers, which is outside the scope of the Agreement.